Skyrizi 360 MG/2.4 ML on-body 2.4ML
Ended Awarded Last action
- Contract number
- SPE2DR26F7VG9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,467
Award facts
- Contract value 100% obligated
- $12,467.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $12,467 delivery order to AmerisourceBergen Drug Corp on January 20, 2026, for the supply of SKYRIZI 360 mg/2.4 ml on-body injectors. This firm fixed-price, competitively awarded contract has an ultimate completion date of February 10, 2026, and represents a tactical pharmaceutical supply requirement fulfilled from the contractor's existing indefinite delivery contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems, with its parent company being Cencora, Inc.
This delivery order is executed under AmerisourceBergen's significant IDC with DLA Troop Support Medical valued at up to $999,999,999 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. The IDC enables the company to supply a broad range of pharmaceutical products, specialty medications, brand-name and generic drugs, and medical supplies to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The absence of a set-aside designation indicates this award was competitively procured, consistent with the company's track record of successfully competing for federal pharmaceutical contracts.
Quick answers
Who was awarded contract SPE2DR26F7VG9?
SPE2DR26F7VG9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26F7VG9 worth?
The government has obligated $12,467 on SPE2DR26F7VG9.
Is contract SPE2DR26F7VG9 an order under another contract?
Yes. SPE2DR26F7VG9 is a delivery order under SPE2DR25D2216, an indefinite delivery contract.
Was contract SPE2DR26F7VG9 competed?
The extent of competition for SPE2DR26F7VG9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award